Cargando…

Progress in 3D Bioprinting Technology for Osteochondral Regeneration

Osteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptom...

Descripción completa

Detalles Bibliográficos
Autores principales: Lafuente-Merchan, Markel, Ruiz-Alonso, Sandra, García-Villén, Fátima, Gallego, Idoia, Gálvez-Martín, Patricia, Saenz-del-Burgo, Laura, Pedraz, Jose Luis
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414312/
https://www.ncbi.nlm.nih.gov/pubmed/36015207
http://dx.doi.org/10.3390/pharmaceutics14081578
_version_ 1784775957847998464
author Lafuente-Merchan, Markel
Ruiz-Alonso, Sandra
García-Villén, Fátima
Gallego, Idoia
Gálvez-Martín, Patricia
Saenz-del-Burgo, Laura
Pedraz, Jose Luis
author_facet Lafuente-Merchan, Markel
Ruiz-Alonso, Sandra
García-Villén, Fátima
Gallego, Idoia
Gálvez-Martín, Patricia
Saenz-del-Burgo, Laura
Pedraz, Jose Luis
author_sort Lafuente-Merchan, Markel
collection PubMed
description Osteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptoms. The increase in the age of the population, along with the increase in risk factors such as obesity, has led OA to the forefront of disabling diseases. In addition, it not only has an increasing prevalence, but is also an economic burden for health systems. Current treatments are focused on relieving pain and inflammation, but they become ineffective as the disease progresses. Therefore, new therapeutic approaches, such as tissue engineering and 3D bioprinting, have emerged. In this review, the advantages of using 3D bioprinting techniques for osteochondral regeneration are described. Furthermore, the biomaterials, cell types, and active molecules that are commonly used for these purposes are indicated. Finally, the most recent promising results for the regeneration of cartilage, bone, and/or the osteochondral unit through 3D bioprinting technologies are considered, as this could be a feasible therapeutic approach to the treatment of OA.
format Online
Article
Text
id pubmed-9414312
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-94143122022-08-27 Progress in 3D Bioprinting Technology for Osteochondral Regeneration Lafuente-Merchan, Markel Ruiz-Alonso, Sandra García-Villén, Fátima Gallego, Idoia Gálvez-Martín, Patricia Saenz-del-Burgo, Laura Pedraz, Jose Luis Pharmaceutics Review Osteochondral injuries can lead to osteoarthritis (OA). OA is characterized by the progressive degradation of the cartilage tissue together with bone tissue turnover. Consequently, joint pain, inflammation, and stiffness are common, with joint immobility and dysfunction being the most severe symptoms. The increase in the age of the population, along with the increase in risk factors such as obesity, has led OA to the forefront of disabling diseases. In addition, it not only has an increasing prevalence, but is also an economic burden for health systems. Current treatments are focused on relieving pain and inflammation, but they become ineffective as the disease progresses. Therefore, new therapeutic approaches, such as tissue engineering and 3D bioprinting, have emerged. In this review, the advantages of using 3D bioprinting techniques for osteochondral regeneration are described. Furthermore, the biomaterials, cell types, and active molecules that are commonly used for these purposes are indicated. Finally, the most recent promising results for the regeneration of cartilage, bone, and/or the osteochondral unit through 3D bioprinting technologies are considered, as this could be a feasible therapeutic approach to the treatment of OA. MDPI 2022-07-29 /pmc/articles/PMC9414312/ /pubmed/36015207 http://dx.doi.org/10.3390/pharmaceutics14081578 Text en © 2022 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Review
Lafuente-Merchan, Markel
Ruiz-Alonso, Sandra
García-Villén, Fátima
Gallego, Idoia
Gálvez-Martín, Patricia
Saenz-del-Burgo, Laura
Pedraz, Jose Luis
Progress in 3D Bioprinting Technology for Osteochondral Regeneration
title Progress in 3D Bioprinting Technology for Osteochondral Regeneration
title_full Progress in 3D Bioprinting Technology for Osteochondral Regeneration
title_fullStr Progress in 3D Bioprinting Technology for Osteochondral Regeneration
title_full_unstemmed Progress in 3D Bioprinting Technology for Osteochondral Regeneration
title_short Progress in 3D Bioprinting Technology for Osteochondral Regeneration
title_sort progress in 3d bioprinting technology for osteochondral regeneration
topic Review
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9414312/
https://www.ncbi.nlm.nih.gov/pubmed/36015207
http://dx.doi.org/10.3390/pharmaceutics14081578
work_keys_str_mv AT lafuentemerchanmarkel progressin3dbioprintingtechnologyforosteochondralregeneration
AT ruizalonsosandra progressin3dbioprintingtechnologyforosteochondralregeneration
AT garciavillenfatima progressin3dbioprintingtechnologyforosteochondralregeneration
AT gallegoidoia progressin3dbioprintingtechnologyforosteochondralregeneration
AT galvezmartinpatricia progressin3dbioprintingtechnologyforosteochondralregeneration
AT saenzdelburgolaura progressin3dbioprintingtechnologyforosteochondralregeneration
AT pedrazjoseluis progressin3dbioprintingtechnologyforosteochondralregeneration